top of page

The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease

  • blonca9
  • Apr 10, 2024
  • 1 min read

Bill Sibold describes how Madrigal has prepared for the launch, visually illustrates how the medicine is meant to impact disease progression, and shares his opinion on whether GLPs could potentially compete in this indication one day in the future.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

bottom of page